As Tamil Nadu faces nearly 100,000 new cancer cases annually, Founder Dr. Vijayalakshmi Balakrishnan scales decentralized daycare chemotherapy while pioneering healthcare entrepreneurship as a woman leader.
POONAMALLEE, CHENNAI — 18/08/2026 — Jus’ Onco, a specialized healthcare network dedicated to making world-class cancer treatment accessible and affordable, today announced the opening of its 4th center in Poonamallee, alongside plans to roll out 3 additional facilities across Tamil Nadu in the coming months.
Located at JKJ Towers, Poonamallee High Road (Kumananchavadi), the new facility expands Jus’ Onco’s established presence in Kodambakkam, Kanchipuram (Launched on 10/07/2026), and Anna Nagar. The rapid expansion addresses a critical gap in Tamil Nadu’s healthcare landscape, where long travel distances and high inpatient hospital fees often force families to delay or abandon vital cancer care.
About the Founder: A Clinician-Entrepreneur Bridging Critical Care Gaps Dr. Vijayalakshmi Balakrishnan is a renowned medical leader with over two decades of clinical experience in Chennai. She completed her MBBS at Stanley Medical College and MD at Madras Medical College, later earning prestigious international fellowships including MRCP (UK), FRCP (Glasgow & Edinburgh), and a Diploma in Tropical Medicine & Hygiene (DTM&H, London). She further strengthened her administrative expertise by completing an Executive MBA in Healthcare from the Indian School of Business (ISB).
Having served as Head of Department and Senior Consultant across premier institutions like Kauvery Hospital, SIMS Hospital, Apollo Hospitals, and CMC Vellore, her work during the COVID-19 pandemic earned her major honors including the Times of India Power Women Award and the Mayan Award. Drawing on her clinical mastery and healthcare management background, she established Jus’ Onco to transition routine cancer therapies out of expensive tertiary care settings and into accessible community hubs.
Addressing Tamil Nadu’s Escalating Cancer Burden According to state registry data, Tamil Nadu records approximately 90,000 to 100,000 new cancer cases every year. For millions living outside central hospital hubs, receiving routine chemotherapy or biological therapies means enduring exhausting commutes and paying exorbitant OPD or room charges at central metro institutions.
Jus’ Onco’s standalone daycare chemotherapy model eliminates these systemic barriers. Patients receive protocol-driven chemotherapy, targeted therapies, and immunotherapy during daytime visits and return home the same day—reducing out-of-pocket treatment costs by up to 40–50% compared to traditional hospital admissions.
Key features of the Poonamallee setup and upcoming centers include:
- Decentralized Daycare Chemotherapy: High-standard infusion protocols managed by dedicated oncology nurses and specialists.
- Integrated Diagnostics & Consultations: Structured screenings, second opinions, and unhurried consultations.
- Free At-Home Palliative Care: Seamless connection with the Jus’ Onco Palliative Care Trust, providing free home-based pain management and caregiver support for terminal cancer patients. Breaking Barriers: Female Leadership in Healthcare Scaling
Building a decentralized healthcare chain in a capital-intensive, traditionally male-dominated medical landscape comes with distinct challenges. As a physician-entrepreneur, Dr. Vijayalakshmi Balakrishnan has navigated the complexities of scaling medical infrastructure, securing capital, and building multi-specialty clinical trust while maintaining an uncompromising commitment to low-cost, ethical patient care.
“Healthcare entrepreneurship as a woman—especially in a high-stakes, capital-heavy field like oncology—requires constantly proving that clinical empathy and financial sustainability can go hand in hand,” said Dr. Vijayalakshmi Balakrishnan, Founder & Director of Jus’ Onco. “When a family receives a cancer diagnosis, the logistical and financial strain can be as crushing as the disease itself. With Tamil Nadu recording nearly 100,000 new cases every year, central metro hospitals simply cannot be the only answer. Opening Poonamallee as our 4th center—and committing to 3 more centers shortly—is about taking world-class daycare chemotherapy directly to patients’ neighborhoods. We are proving that scalable healthcare can be built on compassion, accessibility, and uncompromised medical excellence.”
Roadmap to 7 Centers Following the Poonamallee launch, Jus’ Onco is actively setting up 3 additional centers in high-need industrial and tier-2 corridors across Tamil Nadu. This phase of expansion will consolidate Jus’ Onco’s position as Tamil Nadu’s leading community-based daycare oncology network.
About Jus’ Onco Jus’ Onco is a network of standalone daycare chemotherapy and oncology centers in Tamil Nadu. Founded by Dr. Vijayalakshmi Balakrishnan, Jus’ Onco delivers affordable, evidence-based chemotherapy, targeted therapy, screening, and free home-based palliative care.
- Phone: +91 44 4777 1777 / +91 6379 123455
- Poonamallee Address: JKJ Towers, No. 2, Poonamallee High Road, Kumananchavadi, Poonamallee, Tamil Nadu 600056
- Website: www.jusonco.com
